source
- Sanofi pauses Phase 2 bronchiectasis study of SAR445399 amid new CEO’s portfolio reviewSanofi has halted a Phase 2 trial of its investigational antibody SAR445399 in non‑cystic fibrosis bronchiectasis. The pause was attributed to strategic business reasons linked to an internal portf…
- CDC appoints Erica Schwartz as director and Moderna secures approval for mRNA flu vaccineThe U.S. Centers for Disease Control and Prevention announced that Erica Schwartz has been confirmed as its director, filling a vacancy that has lasted nearly a year. In a separate regulatory upda…